HANGZHOU THINHEAL PHARMA-TECH CO LTD
Overview
HANGZHOU THINHEAL PHARMA-TECH CO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering LINACLOTIDE; RETATRUTIDE; SEMAGLUTIDE; TIRZEPATIDE.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances HANGZHOU THINHEAL PHARMA-TECH CO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
HANGZHOU THINHEAL PHARMA-TECH CO LTD holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- RETATRUTIDEActive2025-12-30
- TIRZEPATIDEActive2024-06-28
- LINACLOTIDEActive2024-06-28
- SEMAGLUTIDEActive2024-06-28
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to HANGZHOU THINHEAL PHARMA-TECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this HANGZHOU THINHEAL PHARMA-TECH CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.